urocortin 2



urocortin 2

I1II1V2VV2L3LL3S4SS4L5LL5D6DD6V7VV7P8PP8I9II9G10GG10L11LL11L12LL12Q13QQ13I14II14L15LL15L16LL16E17EE17Q18QQ18A19AA19R20RR20A21AA21R22RR22A23AA23A24AA24R25RR25E26EE26Q27QQ27A28AA28T29TT29T30TT30N31NN31A32AA32R33RR33I34II34L35LL35A36AA36R37RR37V38VV38

SMILES None
InChIKey PIXFIEBACLDPNF-SKCWXFKWSA-N
Sequence IVLSLDVPIGLLQILLEQARARAAREQATTNARILARV

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


Bioactivities

urocortin 2

I1II1V2VV2L3LL3S4SS4L5LL5D6DD6V7VV7P8PP8I9II9G10GG10L11LL11L12LL12Q13QQ13I14II14L15LL15L16LL16E17EE17Q18QQ18A19AA19R20RR20A21AA21R22RR22A23AA23A24AA24R25RR25E26EE26Q27QQ27A28AA28T29TT29T30TT30N31NN31A32AA32R33RR33I34II34L35LL35A36AA36R37RR37V38VV38

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.